In continuation to its earlier intimation dated 6th March, 2026, 8th April, 2026 and 9th April, 2026, Anlon Healthcare has informed that the Board of Directors of the Company in its meeting held today, 27th April 2026 (the deemed allotment date), allotted 26,57,57,500 equity shares of Rs 2 each as fully paid-up bonus equity shares, in the proportion of 1:1, to the eligible members of the Company whose names appeared in the Register of Members / Register of the Beneficial Owners, as on 24th April 2026, the ‘Record Date’ fixed for this purpose. Consequent to the aforesaid allotment, the paid-up equity share capital of the Company stands increased to Rs. 1,06,30,30,000 divided into 53,15,15,000 equity shares of Rs. 2 each. The meeting commenced at 09:00 am and concluded at 9:15 am.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1824.10 |
| Dr. Reddys Lab | 1287.95 |
| Cipla | 1334.85 |
| Zydus Lifesciences | 901.65 |
| Lupin | 2350.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: